CTRI/2022/09/046021尚未招募未知
To evaluate the role of 18F FDG PET-CT for detection of nociceptive metabolic activity in patients with low backache.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1) Participants between the age of 18 and 75.
- •2) The ability to give written informed consent.
- •3) Ongoing pain that averaged at least 4, on a 0-10 pain scale( visual analogue scale); during a typical week, and present at least 50 percent of days during a typical week.
- •4) On a stable pain treatment.
- •5) Medical records confirming the diagnosis of low back pain.
排除标准
- •1) Breastfeeding or pregnancy.
- •2) blood glucose level > 150mg/dl.
- •3) Inability to provide consent.
- •4) Any suspected spine infection.
- •5) Any known osseous metastatic or other osseous malignancy.
- •6) History of major spine trauma or spinal surgery within six months from the time of scanning.
- •7) Any interventional pain procedures within six weeks before scanning procedure or at any point during study enrollment.
- •8) Past or current history of major psychiatric ilness e.g anxiety, claustrophobia, etc.
研究者
相似试验
已完成
不适用
The Value of PET-CT in Pleural EffusionsPleural Effusion, MalignantNCT03272997Naestved Hospital112
Unknown
早期 1 期
18F-FDG PET/CT for IgG4-Related DiseaseAutoimmune DiseaseNCT01665196Peking Union Medical College Hospital100
已完成
不适用
PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)Fever of Unknown OriginNCT04851379University Hospital, Montpellier44
已完成
不适用
Evaluation of 18F-FDG-PET/CT in the diagnosis and treatment response of bone metastasis.bone metastasisJPRN-UMIN000005866ational Cancer Center Research Projects Management expenses Grants from the Government to National Cancer Research Center220
进行中（未招募）
1 期
Study to see if new research scans can show how treatment affects the blood supply to kidney cancersPrimary and metastatic cancer. The active substance is a diagnostic agent that identifies angiogenesis associated with tumour growth.MedDRA version: 14.1 Level: PT Classification code 10050018 Term: Renal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10038389 Term: Renal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002833-20-GBOxford University Hospitals NHS Trust10